Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2016-05-01 / Am. J. Respir. Crit. Care Med. 2016 05;193(9):1023-31Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2016-04-21 / Radiat Oncol 2016 Apr;11:60Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
/in Dendritic Cells, International Publications /von 2016-04-15 / Clin. Cancer Res. 2016 Apr;22(8):1897-906T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-04-11 / Cancer Res. 2016 06;76(12):3496-506Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2016-03-07 / Tumour Biol. 2016 Aug;37(8):11267-78Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
/in Dendritic Cells, Glioblastoma, Immunogenic Cell Death, International Publications, Prostate Cancer /von 2016-03-02 / Sci Transl Med 2016 Mar;8(328):328ra27Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial
/in Dendritic Cells, HIV/AIDS, International Publications /von 2016-03-01 / J. Acquir. Immune Defic. Syndr. 2016 Mar;71(3):246-53Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2016-02-24 / Oncol Lett 2016 Apr;11(4):2605-2610Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-02-10 / Cancer Immunol. Immunother. 2016 Mar;65(3):327-39IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de